Geriatrics

ANA Investigates Biomarkers for Alzheimer Disease

08/19/2020

 

In this podcast, David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.

David Holtzman

David M. Holtzman, MD, is the Andrew B. and Gretchen P. Jones Professor of Neurology, Charlotte and Paul Hagemann Professor of Neurology, chairman of the Department of Neurology, and professor in the Molecular Biology and Pharmacology Department at Washington University School of Medicine in St. Louis, as well as Neurologist-in-Chief at Barnes-Jewish Hospital in St. Louis, Missouri.

Published in partnership with American Neurological Association

For more ANA investigates podcasts, visit our partners at the American Neurological Association.

Related Content

Mental Health
Mental Health
Marco Solmi, MD, on Patients With Severe Mental Illness Have Increased Risk for CVD
06/08/2017
<p>Dr. Marco Solmi from the University of Padua, Italy, speaks with us about his latest study that assessed the association between mental illness and cardiovascular disease.</p>
06/08/2017
Medication Prescribing
Medication Prescribing
Strategies for Treatment of Chronic Hepatitis C Virus
01/02/2023
In this podcast, Paul Y. Kwo, MD, discusses his research investigating different strategies for treating chronic hepatitis C virus (HCV), as well as why he believes the diagnosis of HVC and...
01/02/2023
Critical Care
Critical Care
The Evolving Critical Care Workforce Crisis: Women Leaders in Critical Care, Ep. 2
12/24/2020
Moderator Jaspal Singh, MD, MHA, MHS, interviews Meeta Kerlin, MD, MSCE, and Sue Stempek, PA-C, about the critical care workforce crisis, how the COVID-19 pandemic affected this crisis, and how being a...
12/24/2020
Diabetes
Diabetes
Lucia Novak, on Clinical Inertia in Diabetes: Key Takeaways for Primary Care
02/04/2019
Lucia Novak, director of Riverside Diabetes Center, gives strategies that may help improve diabetes management and prevent clinical inertia on patient and practitioner levels.
02/04/2019
Gastroenterology
Gastroenterology
Russell Cohen, MD, on Clinical Application of JAK Inhibitors in IBD Patients
08/10/2018
Russell Cohen, MD, from the University of Chicago discusses the use of janus kinase inhibitors for the treatment of inflammatory bowel disease, a topic in which he presented at IBD Clinical...
08/10/2018